Objective This clinical study aimed to evaluate the clinical performance of an alkasite-based bioactive material by comparing it with a resin composite (RC) in the restoration of Class II cavities ...

Yet, I assess that Viking Therapeutics’s main growth vector will likely be imputed to its ability to commercialize and ...

A supportive government, modern infrastructure and easily accessible patient population are helping this Asian nation become a top location for clinical trial research. South Korea, a country in ...

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid ...

Reports continued progress in the evaluation of assets for potential in-licensing and development in the areas of oncology and rare disease - - New data from pilot ...

We performed an unblinded, multicenter, clinical-effectiveness ... the basis of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) trial. 4 With these assumptions ...

Yet, some use cases can be more easily applied to almost every clinical trial organisation. This article outlines some practical GenAI use cases in clinical trials and discusses the most popular ...

Zurich (Switzerland), May 22, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives ...

A first-in-human phase 1, multicenter, open-label study of CB-011, a next-generation CRISPR-genome edited allogeneic anti-BCMA immune-cloaked CAR-T cell therapy, in patients with relapsed/refractory ...

Finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist, has favorable effects on cardiorenal outcomes in patients with predominantly stage 3 or 4 chronic kidney disease (CKD ...